Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: July News from our Partners at Consultant360

Demystifying Diabetes: Nutrition411: The Podcast, Ep. 4
In this episode, Lisa Jones, MA, RDN, LDN, FAND, interviews Priscilla F. Thomas, MS, RN, RDN, LDN, CDCES, CCM, and Sandra Arevalo MPH, RDN, CDN, CDE, CLC, FADA, on diabetes management, including common diabetes misconceptions, the future of diabetes management, and interventions in the promotion of health. 

Cannabis and Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Consultant360 spoke with lead author Greg Kinney, PhD, about his study, which found that cannabis use may be associated with an increased risk for diabetic ketoacidosis in patients with type 1 diabetes. Dr. Kinney is research assistant professor in the Department of Epidemiology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado.

Hemoglobin A1c Variation and Correlation With Time in Nondiabetes, Including Prediabetes
The purpose of the study is to determine whether hemoglobin A1c in nondiabetes (which includes prediabetes) inevitably rises with time. A retrospective data review of 5742 serial A1c measurements performed on 2089 patients (including patients with prediabetes) meeting the criteria of not having diabetes and having at least 2 A1c measurements performed during the 33-month study period was analyzed for correlation or covariance with time.

Test Your Knowledge of Resistant Hypertension: Established CVD or CKD
In part 1 of our “Test Your Knowledge” series, Michael Bloch, MD, asks you to pick the patient vignette that best defines resistant hypertension as defined by the ACC/AHA.

SGLT-2 Inhibitors for Heart Failure
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a session she recently presented at ADCES21, on the use of SGLT-2 inhibitors in patients with heart failure.